Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

This study has been terminated.
(Sponsor Decision- Financial Considerations)
Sponsor:
Information provided by (Responsible Party):
Orexigen Therapeutics, Inc
ClinicalTrials.gov Identifier:
NCT00734435
First received: August 12, 2008
Last updated: November 27, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 27, 2012